Brachytherapy
Volume 7, Issue 2 , Page 94, April 2008

Five-year biochemical and clinical outcomes for high-dose-rate and low-dose-rate brachytherapy in the setting of favorable risk prostate cancer

  • Samuel McGrath, M.D.

      Affiliations

    • Radiation Oncology, William Beaumont Hospital, Royal Oak, MI
    • ,
  • Alvaro A. Martinez, M.D.

      Affiliations

    • Radiation Oncology, William Beaumont Hospital, Royal Oak, MI
    • ,
  • D. Jeffrey Demanes, M.D.

      Affiliations

    • Radiation Oncology, California Endocurietherapy Cancer Center, Oakland, CA
    • ,
  • Michel Ghilezan, M.D.

      Affiliations

    • Radiation Oncology, William Beaumont Hospital, Royal Oak, MI
    • ,
  • Lionel Schour, M.D.

      Affiliations

    • Radiation Oncology, California Endocurietherapy Cancer Center, Oakland, CA
    • ,
  • Christine Mitchell, R.N.

      Affiliations

    • Radiation Oncology, William Beaumont Hospital, Royal Oak, MI
    • ,
  • J. Vito Antonucci, M.D.

      Affiliations

    • Radiation Oncology, William Beaumont Hospital, Royal Oak, MI
    • ,
  • Gary S. Gustafson, M.D.

      Affiliations

    • Radiation Oncology, William Beaumont Hospital, Royal Oak, MI

OR6 Presentation Time: 3:50 PM

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1538-4721(08)00398-X

doi:10.1016/j.brachy.2008.02.342

Brachytherapy
Volume 7, Issue 2 , Page 94, April 2008

Article Tools